What type of study is this?

This is a Systematic Review study (also classified as: Meta-Analysis).

Epstein-Barr virus (EBV) associated post transplantation lymphoproliferative disease (PTLD) in hematopoietic stem cell transplantation (HSCT): a prevalence based systematic review and meta-analysis on global epidemiology

View Full Paper

Ask AI

Bookmark

Authors

Systematic review finds 27% prevalence of EBV-associated PTLD in HSCT patients globally, indicating urgent need for detection.

Overall prevalence of EBV-associated PTLD in HSCT was 27.0%, revealing significant public health implications.
The highest prevalence of 33.3% was observed in North America, with Europe and Asia following at 27.8% and 20.7% respectively.
Assessment involved a systematic review and meta-analysis of 33 studies selected from 941 articles across key medical databases.
Addressing early detection and personalized treatment strategies could enhance outcomes for HSCT patients.

Mustafa et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark